Induction and Maintenance of Clinical Remission by Adalimumab in Patients With Moderate-to-Severe Ulcerative Colitis

被引：1
|
作者：
Sandborn, William J.
Van Assche, Gert A.
Reinisch, Walter
Colombel, Jean-Frederic
D'Haens, Geert R.
Wolf, Douglas C.
Kron, Martina
Tighe, Mary Beth
Lazar, Andreas
Thakkar, Roopal
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S123 / S124
页数：2
相关论文
共 50 条
  • [31] Prebiotics for induction and maintenance of remission in ulcerative colitis
    Sinopoulou, Vassiliki
    Gordon, Morris
    Gregory, Vicki
    Saadeh, Anas
    Akobeng, Anthony K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (03):
  • [32] Antibiotics for the induction and maintenance of remission in ulcerative colitis
    Gordon, Morris
    Sinopoulou, Vassiliki
    Grafton-Clarke, Ciaran
    Akobeng, Anthony K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (05):
  • [33] Vedolizumab for induction and maintenance of remission in ulcerative colitis
    Bickston, Stephen J.
    Behm, Brian W.
    Tsoulis, David J.
    Cheng, Jianfeng
    MacDonald, John K.
    Khanna, Reena
    Feagan, Brian G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [34] Risankizumab for Induction and Maintenance of Remission in Ulcerative Colitis
    Roshanov, Pavel s.
    Khanna, Reena
    GASTROENTEROLOGY, 2025, 168 (03)
  • [35] Adalimumab Versus Infliximab in Inducing Mucosal Healing in Moderate-to-Severe Ulcerative Colitis: A Cost-Per-Remission Decision Analytic Study
    Park, K. T.
    Yokomizo, L.
    GASTROENTEROLOGY, 2015, 148 (04) : S199 - S199
  • [36] Effectiveness of upadacitinib for induction of remission in moderate-to-severe ulcerative colitis: real-world clinical outcomes appear independent of prior tofacitinib exposure
    Gonzalez, A. Elosua
    Zabalza, L.
    Vicuna, M.
    Rubio, S.
    Nantes, O.
    Rodriguez, C.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1295 - i1295
  • [37] Cost-Effectiveness of Infliximab Scheduled Maintenance Treatment for the Management of Patients With Moderate-to-Severe Ulcerative Colitis
    Monfared, Amir A. Tahami
    Feagan, Brian G.
    GASTROENTEROLOGY, 2013, 144 (05) : S637 - S637
  • [38] Induction of response and remission: a network meta-analysis of induction studies comparing ontamalimab with other treatments for moderate-to-severe ulcerative colitis
    Vickers, A.
    Nag, A.
    Devine, B.
    Sands, B. E.
    Panaccione, R.
    Peyrin-Biroulet, L.
    Danese, S.
    Vermeire, S.
    Gorelick, K. J.
    Goetsch, M.
    Hartley, L.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S327 - S328
  • [39] Cyclosporine A for induction of remission in severe ulcerative colitis
    Shibolet, O
    Regushevskaya, E
    Brezis, M
    Soares-Weiser, K
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01):
  • [40] Clinical Remission Using the Patient-Reported Ulcerative Colitis Electronic Diary (UC e-Diary) in Adults With Moderate-to-Severe Ulcerative Colitis
    Tahir, Muna J.
    Shahraz, Saeid
    Kamble, Pravin
    Wang, Song
    Nagy, Peter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S427 - S427
12345